Dietmar P Rabussay
CIK 1260935 · View on SEC EDGAR ↗
First SEC filing: March 1, 2005 · Latest: March 1, 2005
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 11, 2004 | INO | S | 250 | $3.41 | $852 | 17,386 Direct | -1.42% | Disposed | -99.3% (price as of 2026-08-21) |
| Sept. 16, 2004 | INO | P | 514 | $8.80 | $4,523 | 514 Direct | — | Acquired | -99.7% (price as of 2026-08-21) |
| Sept. 16, 2004 | INO | P | 1 | $5882.35 | $5,882 | 1 Direct | — | Acquired | -100.0% (price as of 2026-08-21) |
| Dec. 22, 2003 | INO | S | 20,000 | $1.16 | $23,200 | 70,362 Direct | -22.13% | Disposed | -99.4% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 8, 2007 | INO | Common Stock Option | Common Stock (25,000) | $3.16 | March 8, 2017 | 25,000 | Acquired |
| March 8, 2006 | INO | Inovio Biomedical Corporation | Inovio Biomedical Corporation Common Stock (35,000) | $2.89 | March 8, 2016 | 35,000 | Acquired |
| Feb. 25, 2005 | INO | Genetronics Biomedical Corporation Common Stock | Genetronics Biomedical Corporation Common Stock (10,000) | $4.46 | Feb. 24, 2015 | 10,000 | Acquired |
| Sept. 16, 2004 | INO | Genetronics Biomedical Corporation Common Stock Warrants | Genetronics Biomedical Corporation Common Stock | $8.80 | May 10, 2009 | 514 | Acquired |
| Aug. 8, 2003 | INO | Common Stock | Common Stock (79,750) | $0.63 | Aug. 7, 2013 | 79,750 | Acquired |
| July 7, 2003 | INO | Warrants | Common Stock (25,532) | $0.65 | July 7, 2003 | 25,532 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
INO
Vice President, Research and Development| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2007 | $185,391 | — | — | $63,927 | — | — | $5,200 | $254,518 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.